New study maps disease progression in Parkinson's and MSA
NCT ID NCT05699460
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 150 people with early Parkinson's disease or Multiple System Atrophy (MSA) for up to 18 months. Researchers will measure changes in motor symptoms, quality of life, and biomarkers to better understand how these diseases progress. The goal is to gather information that could help design future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help researchers better understand how Parkinson's disease and Multiple System Atrophy progress, potentially guiding future treatments.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new therapy, and results may not lead directly to new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mazowiecki Szpital Bródnowski w Warszawie, Oddział Neurologii
Warsaw, Poland
-
OHSU Parkinson Center & Movement Disorders Program
Portland, Oregon, 97239, United States
-
Ohio Health Research Institute
Columbus, Ohio, 43214, United States
-
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, 33486, United States
-
Quest Research Institute
Farmington Hills, Michigan, 48334, United States
-
Samodzielny Publiczny Szpital Kliniczny im. prof. Witolda Orłowskiego, Oddział Neurologii i Epileptologii
Warsaw, Poland
-
Specjalistyczna Praktyka Lekarska, Prof. Grzegorz Opala
Katowice, Poland
-
University of California Irvine
Irvine, California, 92697, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Zespol Poradni Specjalistycznych - Botaniczna 3 Poradnia Neurologiczna Szpital Uniwersytecki w Krakowie
Krakow, Lesser Poland Voivodeship, Poland